Identification of Porphyromonas gingivalis lipopolysaccharide-binding proteins in human saliva

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 2207-2213

  Choi, Seulggie ^a   Baik, Jung Eun ^a   Jeon, Jun Ho ^a   Cho, Kun ^b   Seo, Deog Gyu ^a   Kum, Kee Yeon ^a   Yun, Cheol Heui ^a   Han, Seung Hyun ^a  

^a Seoul National University   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Lipopolysaccharide; Lipopolysaccharide binding proteins; Mass spectrometry; Porphyromonas gingivalis; Saliva

Indexed keywords

AMYLASE; ANDROGEN; CD14 ANTIGEN; CYSTATIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LIPOCALIN 1; LIPOPOLYSACCHARIDE BINDING PROTEIN; LYSOZYME CHLORIDE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROLACTIN; SEPHAROSE; SERUM ALBUMIN; SUCCINIMIDE DERIVATIVE; TOLL LIKE RECEPTOR 2;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; CONTROLLED STUDY; FOURIER TRANSFORM MASS SPECTROMETRY; GENE EXPRESSION SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; MACROPHAGE; MASS SPECTROMETRY; MEDIATOR RELEASE; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN IMMOBILIZATION; PROTEIN PURIFICATION; SALIVA ANALYSIS;

ACUTE-PHASE PROTEINS; ANIMALS; CARRIER PROTEINS; HUMANS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; PORPHYROMONAS GINGIVALIS; SALIVA; SALIVARY PROTEINS AND PEPTIDES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

BACTERIA (MICROORGANISMS); PORPHYROMONAS GINGIVALIS;

EID: 80051945663     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.06.434     Document Type: Article

References (47)

1. Anderson N.L., Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1:845-867.
2. Bartold P.M., Marino V., Cantley M., Haynes D.R. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J. Clin. Periodontol. 2010, 37:405-411.
3. Bennick A. Salivary proline-rich proteins. Mol. Cell. Biochem. 1982, 45:83-99.
4. Birkhed D., Skude G. Relation of amylase to starch and Lycasin metabolism in human dental plaque in vitro. Scand. J. Dent. Res. 1978, 86:248-258.
5. Brandenburg K., Koch M.H., Seydel U. Biophysical characterisation of lysozyme binding to LPS Re and lipid A. Eur. J. Biochem. 1998, 258:686-695.
6. Casali P., Notkins A.L. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu. Rev. Immunol. 1989, 7:513-535.
7. Couturier C., Haeffner-Cavaillon N., Caroff M., Kazatchkine M.D. Binding sites for endotoxins (lipopolysaccharides) on human monocytes. J. Immunol. 1991, 147:1899-1904.
8. End C., Bikker F., Renner M., Bergmann G., Lyer S., Blaich S., Hudler M., Helmke B., Gassler N., Autschbach F., Ligtenberg A.J., Benner A., Holmskov U., Schirmacher P., Nieuw Amerongen A.V., Rosenstiel P., Sina C., Franke A., Hafner M., Kioschis P., Schreiber S., Poustka A., Mollenhauer J. DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands. Eur. J. Immunol. 2009, 39:833-842.
9. Erridge C., Bennett-Guerrero E., Poxton I.R. Structure and function of lipopolysaccharides. Microbes Infect. 2002, 4:837-851.
10. Flower D.R. The lipocalin protein family: structure and function. Biochem. J. 1996, 318(Pt 1):1-14.
11. Fluckinger M., Haas H., Merschak P., Glasgow B.J., Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob. Agents Chemother. 2004, 48:3367-3372.
12. Freudenberg M.A., Galanos C. Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity. Infect. Immun. 1978, 19:875-882.
13. Gioannini T.L., Zhang D., Teghanemt A., Weiss J.P. An essential role for albumin in the interaction of endotoxin with lipopolysaccharide-binding protein and sCD14 and resultant cell activation. J. Biol. Chem. 2002, 277:47818-47825.
14. Glasgow B.J., Abduragimov A.R., Farahbakhsh Z.T., Faull K.F., Hubbell W.L. Tear lipocalins bind a broad array of lipid ligands. Curr. Eye Res. 1995, 14:363-372.
15. Griffen A.L., Becker M.R., Lyons S.R., Moeschberger M.L., Leys E.J. Prevalence of Porphyromonas gingivalis and periodontal health status. J. Clin. Microbiol. 1998, 36:3239-3242.
16. Hirschfeld M., Weis J.J., Toshchakov V., Salkowski C.A., Cody M.J., Ward D.C., Qureshi N., Michalek S.M., Vogel S.N. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 2001, 69:1477-1482.
17. Henskens Y.M., van den Keijbus P.A., Veerman E.C., Van der Weijden G.A., Timmerman M.F., Snoek C.M., Van der Velden U., Nieuw Amerongen A.V. Protein composition of whole and parotid saliva in healthy and periodontitis subjects. Determination of cystatins, albumin, amylase and IgA. J. Periodontal Res. 1996, 31:57-65.
18. Holler E., Rupley J.A., Hess G.P. Productive and unproductive lysozyme-chitosaccharide complexes. Kinetic investigations. Biochemistry 1975, 14:2377-2385.
19. Holt S.C., Kesavalu L., Walker S., Genco C.A. Virulence factors of Porphyromonas gingivalis. Periodontology 2000 1999, 20:168-238.
20. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
21. Kitchens R.L., Wolfbauer G., Albers J.J., Munford R.S. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J. Biol. Chem. 1999, 274:34116-34122.
22. Liu R., Desta T., Raptis M., Darveau R.P., Graves D.T. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J. Periodontol. 2008, 79:1241-1247.
23. Medvedev A.E., Henneke P., Schromm A., Lien E., Ingalls R., Fenton M.J., Golenbock D.T., Vogel S.N. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of toll-like receptors 2 or 4. J. Immunol. 2001, 167:2257-2267.
24. Miyata Y., Takeda H., Kitano S., Hanazawa S. Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics. Infect. Immun. 1997, 65:3513-3519.
25. Ohno N., Morrison D.C. Lipopolysaccharide interaction with lysozyme. Binding of lipopolysaccharide to lysozyme and inhibition of lysozyme enzymatic activity. J. Biol. Chem. 1989, 264:4434-4441.
26. Ogra P.L., Mestechy J., Lamm M.F., et al. Mucosal Immunology 1999, Academic Press, San Diego. 2nd ed.
27. Orstavik D., Kraus F.W. The acquired pellicle: immunofluorescent demonstration of specific proteins. J. Oral Pathol. 1973, 2:68-76.
28. Pudifin D., L'Hoste I., Duursma J., Gaffin S.L. Opsonisation of gram-negative bacteria by anti-lipopolysaccharide antibodies. Lancet 1985, 2:1009-1010.
29. Redl B. Human tear lipocalin. Biochim. Biophys. Acta 2000, 1482:241-248.
30. Reid R.R., Prodeus A.P., Khan W., Hsu T., Rosen F.S., Carroll M.C. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. J. Immunol. 1997, 159:970-975.
31. Rietschel E.T., Kim Y.B., Watson D.W., Galanos C., Luderitz O., Westphal O. Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect. Immun. 1973, 8:173-177.
32. Scannapieco F.A. Saliva-bacterium interactions in oral microbial ecology. Crit. Rev. Oral Biol. Med. 1994, 5:203-248.
33. Scannapieco F.A., Bergey E.J., Reddy M.S., Levine M.J. Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect. Immun. 1989, 57:2853-2863.
34. Scarano E., Fiorita A., Picciotti P.M., Passali G.C., Calo L., Cabras T., Inzitari R., Fanali C., Messana I., Castagnola M., Paludetti G. Proteomics of saliva: personal experience. Acta Otorhinolaryngol. Ital. 2010, 30:125-130.
35. Schenkels L.C., Walgreen-Weterings E., Oomen L.C., Bolscher J.G., Veerman E.C., Nieuw Amerongen A.V. In vivo binding of the salivary glycoprotein EP-GP (identical to GCDFP-15) to oral and non-oral bacteria detection and identification of EP-GP binding species. Biol. Chem. 1997, 378:83-88.
36. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
37. Shomers J.P., Tabak L.A., Levine M.J., Mandel I.D., Ellison S.A. The isolation of a family of cysteine-containing phosphoproteins from human submandibular-sublingual saliva. J. Dent. Res. 1982, 61:973-977.
38. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998, 25:134-144.
39. Southerland J.H., Taylor G.W., Moss K., Beck J.D., Offenbacher S. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontology 2000 2006, 40:130-143.
40. Takada K., Ohno N., Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect. Immun. 1994, 62:1171-1175.
41. Takada K., Ohno N., Yadomae T. Lysozyme regulates LPS-induced interleukin-6 release in mice. Circ. Shock 1994, 44:169-174.
42. Van Nieuw Amerongen A., Bolscher J.G., Veerman E.C. Salivary proteins: protective and diagnostic value in cariology?. Caries Res. 2004, 38:247-253.
43. Walker D.M. Oral mucosal immunology: an overview. Ann. Acad. Med. Singapore 2004, 33:27-30.
44. Wells M.T., Gaffin S.L., Gregory M., Coovadia Y. Properties of equine anti-lipopolysaccharide hyperimmune plasma: binding to lipopolysaccharide and bactericidal activity against gram-negative bacteria. J. Med. Microbiol. 1987, 24:187-196.
45. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
46. Zhou Z.H., Zhang Y., Hu Y.F., Wahl L.M., Cisar J.O., Notkins A.L. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 2007, 1:51-61.
47. Zweigner J., Gramm H.J., Singer O.C., Wegscheider K., Schumann R.R. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001, 98:3800-3808.